Drugs / QYJD Compound Preparation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06766565 | Dec 2021 → Dec 2022 | non-small cell lung carcinoma | Fuzhou General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QYJD Compound Preparation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06766565 ↗ |
| Route | Oral | “the patients were orally treated with expelling blood stasis and detoxifying compound preparation” NCT06766565 ↗ |